23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) have emerged as independent risk factors for an earlier onset of Alzheimer’s disease (AD), although the pathophysiology underlying this risk is unclear. Postmortem studies have revealed extensive cerebral accumulation of tau following multiple and single TBI incidents. We hypothesized that a history of TBI and/or PTSD may induce an AD-like pattern of tau accumulation in the brain of nondemented war veterans.

          Methods

          Vietnam War veterans (mean age 71.4 years) with a history of war-related TBI and/or PTSD underwent [ 18F]AV145 PET as part of the US Department of Defense Alzheimer’s Disease Neuroimaging Initiative. Subjects were classified into the following four groups: healthy controls ( n = 21), TBI ( n = 10), PTSD ( n = 32), and TBI+PTSD ( n = 17). [ 18F]AV1451 reference tissue-normalized standardized uptake value (SUVr) maps, scaled to the cerebellar grey matter, were tested for differences in tau accumulation between groups using voxel-wise and region of interest approaches, and the SUVr results were correlated with neuropsychological test scores.

          Results

          Compared to healthy controls, all groups showed widespread tau accumulation in neocortical regions overlapping with typical and atypical patterns of AD-like tau distribution. The TBI group showed higher tau accumulation than the other clinical groups. The extent of tauopathy was positively correlated with the neuropsychological deficit scores in the TBI+PTSD and PTSD groups.

          Conclusion

          A history of TBI and/or PTSD may manifest in neurocognitive deficits in association with increased tau deposition in the brain of nondemented war veterans decades after their trauma. Further investigation is required to establish the burden of increased risk of dementia imparted by earlier TBI and/or PTSD.

          Electronic supplementary material

          The online version of this article (10.1007/s00259-018-4241-7) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Primary age-related tauopathy (PART): a common pathology associated with human aging.

          We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (Aβ) plaques. For these "NFT+/Aβ-" brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of Aβ accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies

            Most neurodegenerative diseases are proteinopathies, which are characterized by the aggregation of misfolded proteins. Although many proteins have an intrinsic propensity to aggregate, particularly when cellular clearance systems start to fail in the context of ageing, only a few form fibrillar aggregates. In Alzheimer disease, the peptide amyloid-β (Aβ) and the protein tau aggregate to form plaques and tangles, respectively, which comprise the histopathological hallmarks of this disease. This Review discusses the complexity of Aβ biogenesis, trafficking, post-translational modifications and aggregation states. Tau and its various isoforms, which are subject to a vast array of post-translational modifications, are also explored. The methodological advances that revealed this complexity are described. Finally, the toxic effects of distinct species of tau and Aβ are discussed, as well as the concept of protein 'strains', and how this knowledge can facilitate the development of early disease biomarkers for stratifying patients and validating new therapies. By targeting distinct species of Aβ and tau for therapeutic intervention, the way might be paved for personalized medicine and more-targeted treatment strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Posttraumatic stress disorder and risk of dementia among US veterans.

              Posttraumatic stress disorder (PTSD) is highly prevalent among US veterans because of combat and may impair cognition. To determine whether PTSD is associated with the risk of developing dementia among older US veterans receiving treatment in the Department of Veterans Affairs medical centers. A stratified, retrospective cohort study conducted using the Department of Veterans Affairs National Patient Care Database. Department of Veterans Affairs medical centers in the United States. A total of 181 093 veterans 55 years or older without dementia from fiscal years 1997 through 2000 (53 155 veterans with and 127 938 veterans without PTSD). During the follow-up period between October 1, 2000, and December 31, 2007, 31 107 (17.2%) veterans were ascertained to have newly diagnosed dementia according to International Classification of Diseases, Ninth Revision, Clinical Modification codes. The mean baseline age of the veterans was 68.8 years, and 174 806 (96.5%) were men. Veterans with PTSD had a 7-year cumulative incident dementia rate of 10.6%, whereas those without had a rate of 6.6% (P < .001). With age as the time scale, Cox proportional hazards models indicated that patients with PTSD were more than twice as likely to develop incident dementia compared with those without PTSD (hazard ratio, 2.31; 95% confidence interval, 2.24-2.39). After multivariable adjustment, patients with PTSD were still more likely to develop dementia (hazard ratio, 1.77; 95% confidence interval, 1.70-1.85). Results were similar when we excluded those with a history of head injury, substance abuse, or clinical depression. In a predominantly male veteran cohort, those diagnosed as having PTSD were at a nearly 2-fold-higher risk of developing dementia compared with those without PTSD. Mechanisms linking these important disorders need to be identified with the hope of finding ways to reduce the increased risk of dementia associated with PTSD.
                Bookmark

                Author and article information

                Contributors
                +61 41 6552512 , a.mohamed@uq.edu.au
                +61 7 33460322 , f.nasrallah@uq.edu.au
                Journal
                Eur J Nucl Med Mol Imaging
                Eur. J. Nucl. Med. Mol. Imaging
                European Journal of Nuclear Medicine and Molecular Imaging
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                1619-7070
                1619-7089
                7 January 2019
                7 January 2019
                2019
                : 46
                : 5
                : 1139-1151
                Affiliations
                [1 ]ISNI 0000 0000 9320 7537, GRID grid.1003.2, Queensland Brain Institute, , University of Queensland, ; Building 79, Upland Road, Saint Lucia, Brisbane, Queensland 4072 Australia
                [2 ]ISNI 0000000089150953, GRID grid.1024.7, School of Psychology and Counselling and IHBI, , Queensland University of Technology, ; Brisbane, QLD 4059 Australia
                [3 ]ISNI 0000 0001 2294 1395, GRID grid.1049.c, QIMR-Berghofer Institute, ; Brisbane, QLD 4006 Australia
                [4 ]ISNI 0000 0000 9320 7537, GRID grid.1003.2, Clem Jones Centre for Ageing Dementia Research (CJCADR), Queensland Brain Institute, , The University of Queensland, ; Brisbane, QLD 4072 Australia
                Article
                4241
                10.1007/s00259-018-4241-7
                6451714
                30617964
                b7ea4c13-0e05-467c-8c6e-f947b409aeed
                © The Author(s) 2019

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 17 July 2018
                : 11 December 2018
                Funding
                Funded by: Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia
                Award ID: 2014000857
                Award Recipient :
                Funded by: Wesley Hospital Medical Research Foundation, Brisbane, Australia
                Award ID: 2016-19
                Award Recipient :
                Categories
                Original Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2019

                Radiology & Imaging
                traumatic brain injury,posttraumatic stress disorder,alzheimer’s disease,tau,positron emission tomography,us department of defense alzheimer’s disease neuroimaging initiative

                Comments

                Comment on this article